You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 6, 2025

Details for Patent: 9,289,446


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,289,446
Title:Myocardial perfusion imaging methods and compositions
Abstract: A myocardial imaging method that is accomplished by administering one or more adenosine A.sub.2A adenosine receptor agonist to a human undergoing myocardial imaging as well as pharmaceutical compositions comprising at least one A.sub.2a receptor agonist, at least one liquid carrier, and at least one co-solvent.
Inventor(s): Belardinelli; Luiz (Palo Alto, CA), Rosner; Mitchell (Mountain View, CA)
Assignee: Gilead Sciences, Inc. (Foster City, CA)
Application Number:14/533,025
Patent Claim Types:
see list of patent claims
Composition; Compound; Device; Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a US Patent: A Detailed Analysis

Introduction

When navigating the complex world of patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the key aspects of patent scope, claims, and the broader patent landscape, using the example of US Patent 9,289,446 to illustrate these concepts.

What is a Patent?

A patent is a government-granted monopoly that gives the inventor exclusive rights to make, use, and sell their invention for a specified period, typically 20 years from the filing date of the patent application[2].

Determining Inventorship

Before diving into the scope and claims, it is essential to identify the true and only inventors of the patentable subject matter. US patent law requires that only those who conceived the idea and reduced it to practice be listed as inventors. Incorrect or incomplete identification of inventors can lead to challenges and potentially render the patent unenforceable[2].

Patent Scope

Patent scope refers to the breadth and depth of protection granted by a patent. It is often debated in the context of "patent quality," with concerns that overly broad patents can stifle innovation due to increased licensing and litigation costs.

Metrics for Measuring Patent Scope

Two simple yet effective metrics for measuring patent scope are independent claim length and independent claim count. These metrics have been shown to have explanatory power for several correlates of patent scope, including patent maintenance payments, forward citations, and the breadth of patent classes. Narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Patent Claims

Patent claims are the heart of a patent, defining the scope of the invention and what is protected. There are different types of claims, including independent and dependent claims.

Independent Claims

Independent claims stand alone and define the invention without reference to other claims. They are crucial because they set the broadest boundaries of the patent's protection.

Dependent Claims

Dependent claims refer back to an independent claim and further limit the scope of the invention. They often provide additional details or specific embodiments of the invention.

Example: US Patent 9,289,446

To illustrate these concepts, let's consider US Patent 9,289,446, though the specific details of this patent are not provided here. Here is how one might analyze it:

Claim Structure

  • Independent Claims: These would define the core aspects of the invention.
  • Dependent Claims: These would provide additional specifics or variations of the invention.

Scope Analysis

  • Independent Claim Length and Count: Analyze the length and number of independent claims to gauge the breadth of the patent.
  • Forward Citations and Maintenance Payments: These can indicate the patent's impact and value within the industry.

The Patent Landscape

Allowance Rates

The probability of receiving a US patent varies significantly. Historically, about 55.8% of patent applications filed at the USPTO between 1996 and 2013 were granted without using continuation procedures. The allowance rate has decreased over time, particularly in fields like "Drugs and Medical Instruments" and "Computers and Communications"[1].

Continuation Applications

Continuation applications can complicate the calculation of allowance rates. These include continuations, continuations-in-part, and divisional applications, which allow applicants to introduce new subject matter or separate claimed inventions[1].

Global Dossier

The Global Dossier service by the USPTO provides a unified platform to access file histories of related applications from participating IP offices. This can be useful for understanding the global patent family and the status of related applications[4].

Challenges in Patent Litigation

Patent litigation can be complex and costly. The idea of a small claims patent court has been explored to address these issues, particularly for smaller entities. Such a court would aim to provide a more streamlined and cost-effective process for resolving patent disputes[5].

Best Practices for Patent Applicants

Thorough Disclosure

Ensure that the invention disclosure is thorough and accurate to avoid issues with inventorship and patent enforceability[2].

Claim Drafting

Carefully draft claims to ensure they are clear, concise, and narrowly focused to increase the likelihood of grant and reduce the risk of litigation[3].

Use of Global Dossier

Utilize the Global Dossier service to track and manage related applications globally, ensuring a comprehensive understanding of the patent landscape[4].

Key Takeaways

  • Patent Scope and Claims: Understanding the metrics and structure of patent claims is crucial for determining the breadth and depth of patent protection.
  • Inventorship: Correctly identifying the true and only inventors is vital for the enforceability of the patent.
  • Patent Landscape: The allowance rates and use of continuation applications can significantly impact the patent process.
  • Global Dossier: This service can help in managing and understanding the global patent family.
  • Patent Litigation: The potential for a small claims patent court highlights the need for efficient and cost-effective dispute resolution mechanisms.

FAQs

What is the average allowance rate for US patent applications?

The average allowance rate for US patent applications is approximately 55.8% without using continuation procedures, though this rate has decreased over time, especially in certain technology fields[1].

How do independent claim length and count affect patent scope?

Narrower and fewer independent claims are associated with a higher probability of grant and a shorter examination process, indicating a more focused and clear patent scope[3].

What is the importance of correct inventorship in a patent application?

Correct inventorship is crucial because it ensures the patent remains enforceable. Incorrect or incomplete identification of inventors can lead to challenges and potential invalidation of the patent[2].

What is the Global Dossier service provided by the USPTO?

The Global Dossier service allows users to access the file histories of related applications from participating IP offices, providing a unified platform to manage and understand the global patent family[4].

Why is there a discussion about a small claims patent court?

The discussion around a small claims patent court aims to address the high costs and complexity of patent litigation, particularly for smaller entities, by providing a more streamlined and cost-effective dispute resolution process[5].

Sources

  1. Carley, M., Hegde, D., & Marco, A. (2015). What Is the Probability of Receiving a US Patent? Yale Journal of Law & Technology, 17, 203.
  2. Gattari, D. (n.d.). Determining Inventorship for US Patent Applications. Oregon State University.
  3. SSRN. (2016). Patent Claims and Patent Scope.
  4. USPTO. (2018). Search for patents.
  5. ACUS. (2022). U.S. Patent Small Claims Court.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,289,446

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.